
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $3.7B | -- | -- | $2.23 | -- |
08/01/2025 | Q2 | $3.4B | -- | -- | $1.40 | -- |
05/01/2025 | Q1 | $2.7B | $2.8B | $0.13 | $0.34 | -$0.21 |
02/27/2025 | Q4 | $3.3B | $3.4B | $0.95 | $1.22 | -$0.27 |
10/31/2024 | Q3 | $3.4B | $3.3B | $1.21 | $1.23 | -$0.02 |
08/01/2024 | Q2 | $3.1B | $3B | $0.43 | $0.87 | -$0.44 |
05/02/2024 | Q1 | $2.6B | $2.7B | -$0.53 | -$0.48 | -$0.05 |
02/29/2024 | Q4 | $3.3B | $3.3B | $0.01 | $0.44 | -$0.43 |
11/02/2023 | Q3 | -- | -- | $0.18 | $1.84 | -$1.66 |
08/03/2023 | Q2 | -- | -- | $0.20 | $0.85 | -$0.65 |
05/04/2023 | Q1 | -- | -- | -$1.05 | -$0.57 | -$0.48 |
02/23/2023 | Q4 | -- | -- | $0.04 | $0.98 | -$0.94 |
11/03/2022 | Q3 | -- | -- | $0.65 | $1.28 | -$0.63 |
08/04/2022 | Q2 | -- | -- | $0.20 | $0.72 | -$0.52 |
05/05/2022 | Q1 | -- | -- | -$0.47 | -$0.11 | -$0.36 |
02/24/2022 | Q4 | -- | -- | $1.04 | $1.28 | -$0.24 |
11/04/2021 | Q3 | -- | -- | $1.50 | $1.69 | -$0.19 |
08/05/2021 | Q2 | -- | -- | $1.02 | $1.23 | -$0.21 |
05/06/2021 | Q1 | -- | -- | $0.89 | $0.77 | $0.12 |
02/25/2021 | Q4 | -- | -- | $1.54 | $1.66 | -$0.12 |
10/29/2020 | Q3 | -- | -- | $1.59 | $1.66 | -$0.07 |
07/30/2020 | Q2 | -- | -- | $0.78 | $0.79 | -$0.01 |
04/30/2020 | Q1 | -- | -- | $0.48 | $0.46 | $0.02 |
02/27/2020 | Q4 | -- | -- | $1.33 | $1.26 | $0.07 |
10/31/2019 | Q3 | -- | -- | $1.69 | $1.62 | $0.07 |
08/01/2019 | Q2 | -- | -- | $1.58 | $1.12 | $0.46 |
05/03/2019 | Q1 | -- | -- | $0.57 | $0.43 | $0.14 |
02/28/2019 | Q4 | -- | -- | $0.41 | $1.06 | -$0.65 |
11/01/2018 | Q3 | -- | -- | $1.52 | $1.25 | $0.27 |
08/02/2018 | Q2 | -- | -- | $1.01 | -- | -- |
04/30/2018 | Q1 | -- | -- | $0.32 | -- | -- |
02/27/2018 | Q4 | -- | -- | $1.95 | -- | -- |
11/02/2017 | Q3 | -- | -- | $0.77 | -- | -- |
08/03/2017 | Q2 | -- | -- | $0.99 | -- | -- |
05/04/2017 | Q1 | -- | -- | $0.50 | -- | -- |
02/23/2017 | Q4 | -- | -- | $0.66 | -- | -- |
11/04/2016 | Q3 | -- | -- | $0.69 | -- | -- |
08/04/2016 | Q2 | -- | -- | $0.30 | -- | -- |
05/06/2016 | Q1 | -- | -- | -$0.03 | -- | -- |
02/26/2016 | Q4 | -- | -- | -$0.96 | -- | -- |
11/04/2015 | Q3 | -- | -- | $0.09 | -- | -- |
MasTec reported $2.8B worth of top line sales in its most recent quarter.
MasTec announced earnings per share of $0.13 which represents a miss of analyst forecast a $0.34 per share.
MasTec reported $311.1M that represents $3.94 per share over the last quarter.
MasTec's earnings are forecast to grow from $2.06 per share to $3.72 per share next year representing an increase of 195.03%.
MasTec's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.